<?xml version="1.0" encoding="UTF-8"?>
<ref id="B125-molecules-26-01107">
 <label>125.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Medhat</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>El-Mezayen</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>El-Naggar</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Farrag</surname>
    <given-names>A.R.</given-names>
   </name>
   <name>
    <surname>Abdelgawad</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Hussein</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kamal</surname>
    <given-names>M.H.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation of urinary 8-hydroxy-2-deoxyguanosine level in experimental Alzheimerâ€™s disease: Impact of carvacrol nanoparticles</article-title>
  <source>Mol. Biol. Rep.</source>
  <year>2019</year>
  <volume>46</volume>
  <fpage>4517</fpage>
  <lpage>4527</lpage>
  <pub-id pub-id-type="doi">10.1007/s11033-019-04907-3</pub-id>
  <?supplied-pmid 31209743?>
  <pub-id pub-id-type="pmid">31209743</pub-id>
 </element-citation>
</ref>
